THE STATE OF THE HEMOSTASIS SYSTEM IN PATIENTS WITH COVID-19

Abstract

Coronavirus infection (COVID-19) is an acute infectious disease caused by the SARS-CoV-2 virus and characterized by activation of the hemostasis system. As a result of this, severe conditions can develop, i.e. coagulopathy. It remains unclear whether COVID-19 is the direct cause of these conditions or whether they occur during the development of an infectious process. The incidence of asymptomatic and clinically evident thrombotic thromboembolic complications in COVID-19 remains unclear. This situation is largely due to the difficulties of diagnosis. However, according to some reports, the frequency of venous and arterial thrombosis in patients with COVID-19 is significantly higher. At the same time, the features of the course of the disease aroused interest in terms of searching and studying its causing factors and caused a lot of discussion.